Email not displaying correctly? View it in your browser.
November 2018

Patient Care

Stealth approach lowers the risk of tissue damage for patients with deep-seated brain lesions
Minimally invasive surgery using a tubular retractor system can be an option for selected patients with subcortical high-grade glioma, metastatic brain tumors or vascular lesions.

New guideline recommends starting colon cancer screening at age 45
American Cancer Society now recommends that regular screening for colorectal cancer should begin at age 45 for adults at average risk. Recent data show a marked increase in the incidence of colorectal cancer in younger and middle-aged populations.


Research suggests a role for screening in adults at high risk of pancreatic cancer
A study of the outcomes associated with abdominal imaging screening for asymptomatic adults at high risk of pancreatic cancer shows that performing EUS and MRI in those individuals identifies a significant number of pancreatic lesions.

Dietary supplement may block the growth of HER2-positive breast cancer cells
Research indicates that cyclocreatine, a dietary supplement used in sports drinks, effectively targets mitochondrial creatine kinase 1 enzyme and reduces the growth of HER2-positive cancer cells without toxicity.

Researchers work to determine a polyp's risk of progression to colon cancer
Researchers using next-generation sequencing techniques to molecularly characterize and compare colon polyps associated with cancer with those that are benign found that polyps adjacent to cancerous tissue exhibited distinct genetic alterations from polyps that remained cancer-free.

Early-phase cancer clinical trials available at Mayo Clinic
The Early Cancer Therapeutics Group offers patients whose cancers haven't responded to standard chemotherapy or other treatments the opportunity to join an early-phase clinical trial (phase I) of a potential new treatment.

See all Cancer Clinical Trials at Mayo Clinic

Back to Top


16th Annual Mayo Clinic Hematology Review 2019
Jan. 19, 2019, in Minneapolis
This program provides an overview of recent advances in the treatment of various hematologic malignancies and their clinical relevance to practice, based on abstracts presented at the December 2018 annual meeting of the American Society of Hematology.

Mayo Clinic Practical Proton Therapy Seminar and Workshop
Jan. 24-26, 2019, in Scottsdale, Ariz.
Lectures feature basic principles of proton beam therapy and proton beam clinical trials, plus case-based vignettes. An interactive workshop provides hands-on demonstrations of patient immobilization at CT simulation, treatment planning and evaluation, image-guided radiation therapy, and IGRT and beam delivery.

Practical Neuroradiology: Excellence Through Evidence and Guidelines
Feb. 10-14, 2019, in Whistler, British Columbia, Canada
Topics include pediatric face, neck and spine imaging; imaging features of salivary gland disease; the normal and diseased craniocervical junction; imaging of inflammatory disease and postoperative change in the temporal bone; and imaging in evaluating and treating patients with cerebrospinal fluid hypotension.

See all Hematology and Oncology Continuous Professional Development courses

In the Video Center

New tumor-shrinking nanoparticle to fight cancer, prevent recurrence
Betty Y S (Betty) Kim, M.D., Ph.D., discusses a new type of cancer-fighting nanoparticle that produced potent anti-tumor immune responses to HER2-positive breast cancers. Mice treated with these nanoparticles also showed resistance to future tumor recurrence.

View videos by specialty and Grand Rounds presentations online

Back to Top

Consults & Referrals

Connect With Us

Facebook iconTwitter iconYoutube icon

Receive real-time news and thought-leading insight

Back to Top

Mayo Clinic
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905